1. Home
  2. VRAR vs CTXR Comparison

VRAR vs CTXR Comparison

Compare VRAR & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAR
  • CTXR
  • Stock Information
  • Founded
  • VRAR 2016
  • CTXR 2007
  • Country
  • VRAR United States
  • CTXR United States
  • Employees
  • VRAR N/A
  • CTXR N/A
  • Industry
  • VRAR Retail: Computer Software & Peripheral Equipment
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • VRAR Technology
  • CTXR Health Care
  • Exchange
  • VRAR Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • VRAR 21.9M
  • CTXR 19.8M
  • IPO Year
  • VRAR 2021
  • CTXR N/A
  • Fundamental
  • Price
  • VRAR $1.20
  • CTXR $1.49
  • Analyst Decision
  • VRAR Strong Buy
  • CTXR Buy
  • Analyst Count
  • VRAR 1
  • CTXR 2
  • Target Price
  • VRAR $2.62
  • CTXR $6.00
  • AVG Volume (30 Days)
  • VRAR 122.1K
  • CTXR 570.6K
  • Earning Date
  • VRAR 11-13-2025
  • CTXR 12-26-2025
  • Dividend Yield
  • VRAR N/A
  • CTXR N/A
  • EPS Growth
  • VRAR N/A
  • CTXR N/A
  • EPS
  • VRAR N/A
  • CTXR N/A
  • Revenue
  • VRAR $9,488,209.00
  • CTXR N/A
  • Revenue This Year
  • VRAR $15.29
  • CTXR N/A
  • Revenue Next Year
  • VRAR $44.54
  • CTXR $731.60
  • P/E Ratio
  • VRAR N/A
  • CTXR N/A
  • Revenue Growth
  • VRAR 16.60
  • CTXR N/A
  • 52 Week Low
  • VRAR $0.67
  • CTXR $0.65
  • 52 Week High
  • VRAR $7.00
  • CTXR $5.95
  • Technical
  • Relative Strength Index (RSI)
  • VRAR 43.17
  • CTXR 59.09
  • Support Level
  • VRAR $1.00
  • CTXR $0.97
  • Resistance Level
  • VRAR $1.22
  • CTXR $1.18
  • Average True Range (ATR)
  • VRAR 0.12
  • CTXR 0.12
  • MACD
  • VRAR -0.00
  • CTXR 0.03
  • Stochastic Oscillator
  • VRAR 42.22
  • CTXR 84.72

About VRAR The Glimpse Group Inc.

The Glimpse Group Inc is a diversified immersive technology platform company, focused on providing enterprise solutions in virtual reality (VR), augmented reality (AR), and spatial computing. The company operates multiple subsidiaries that develop VR and AR software and services across various industries, including corporate training, education, healthcare, government, defense, marketing, retail, and financial services. It also offers AI-driven spatial computing platforms that support simulations, social VR, behavioral health, and corporate events. The Company reports its revenues in three categories: Software Services, Software License and Software-as-a-Service (SaaS), and Royalty Income, with the majority being from the Software Services category.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: